|
|
||||||||
The Journal of Immunology, Vol 154, Issue 12 6306-6313, Copyright © 1995 by American Association of Immunologists
ARTICLES |
A Sundstedt, I Hoiden, J Hansson, G Hedlund, T Kalland and M Dohlsten
Pharmacia Oncology Immunology, Lund, Sweden.
This study describes the use of bacterial superantigens to investigate the mechanisms governing peripheral tolerance in CD8+ T cells. Administration of superantigens to mice activates T cells to proliferation, cytokine production, and cytotoxicity, but responding cells subsequently enter a state of hyporesponsiveness or are deleted. Superantigen-induced inactivation has so far mainly been demonstrated for CD4+ T cells. Injection of amounts of the superantigen staphylococcal enterotoxin A (SEA) that are optimal for T cell activation and which induce anergy in CD4+ T cells result in preserved responsiveness in CD8+ CTLs. In contrast, we found that intravenous injection of low concentrations of SEA induced a profound down- regulation of the cytotoxic function in SEA-reactive CD8+ TCR V beta 11+ T cells. No reduction in the number of CD8+V beta 11+ T cells was found, suggesting that anergy and not deletion is the main mechanism for the observed cytotoxic hyporesponsiveness. The cytotoxic anergy was evident 2 days after low-dose priming and remained present 4 wk later, indicating a rapid induction phase and long-lasting persistence. The anergized CD8+ T cell subset expressed lower levels of the alpha- (CD11a) chain of the cell adhesion molecule lymphocyte function- associated Ag 1 (LFA-1) and failed to mediate cytotoxicity, but retained the capacity to proliferate, express IL-2R, produce IFN-gamma, and express granzyme mRNA, which imply a partial defect in TCR- transduced signals. Taken together, these findings suggest that there is a biphasic stimulus-dependent threshold for acquiring responsiveness or anergy in CD8+ T cells.
This article has been cited by other articles:
![]() |
S. A. Ghanekar, L. E. Nomura, M. A. Suni, L. J. Picker, H. T. Maecker, and V. C. Maino Gamma Interferon Expression in CD8+ T Cells Is a Marker for Circulating Cytotoxic T Lymphocytes That Recognize an HLA A2-Restricted Epitope of Human Cytomegalovirus Phosphoprotein pp65 Clin. Vaccine Immunol., May 1, 2001; 8(3): 628 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Miyamoto, E. R. Wann, T. Fowler, E. Duffield, M. Hook, and B. W. McIntyre Fibronectin Binding Protein A of Staphylococcus aureus Can Mediate Human T Lymphocyte Adhesion and Coactivation J. Immunol., April 15, 2001; 166(8): 5129 - 5138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grundstrom, M. Dohlsten, and A. Sundstedt IL-2 Unresponsiveness in Anergic CD4+ T Cells Is Due to Defective Signaling Through the Common {gamma}-Chain of the IL-2 Receptor J. Immunol., February 1, 2000; 164(3): 1175 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Nugent, D. J. Morgan, J. A. Biggs, A. Ko, I. M. Pilip, E. G. Pamer, and L. A. Sherman Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas J. Immunol., January 1, 2000; 164(1): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shrikant and M. F. Mescher Control of Syngeneic Tumor Growth by Activation of CD8+ T Cells: Efficacy Is Limited by Migration Away from the Site and Induction of Nonresponsiveness J. Immunol., March 1, 1999; 162(5): 2858 - 2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Ferens, W. C. Davis, M. J. Hamilton, Y. H. Park, C. F. Deobald, L. Fox, and G. Bohach Activation of Bovine Lymphocyte Subpopulations by Staphylococcal Enterotoxin C Infect. Immun., February 1, 1998; 66(2): 573 - 580. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |